Aquestive Therapeutics
AQST
AQST
115 hedge funds and large institutions have $158M invested in Aquestive Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 53 increasing their positions, 26 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less call options, than puts
Call options by funds: $729K | Put options by funds: $1.17M
Holders
115
Holding in Top 10
2
Calls
$729K
Puts
$1.17M
Top Buyers
| 1 | +$7.81M | |
| 2 | +$1.59M | |
| 3 | +$1.55M | |
| 4 |
EAM
Everstar Asset Management
Mooresville,
North Carolina
|
+$1.03M |
| 5 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
+$977K |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$3.04M | |
| 3 | -$882K | |
| 4 |
Goldman Sachs
New York
|
-$844K |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$549K |